Boothbay Fund Management’s Erasca ERAS Stock Holding History

Boothbay Fund Management’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-188,467	Closed	-$701K	–	2178
2025 Q4	$701K	Buy	+188,467	New	+$530K	0.01%	969

Other funds holding ERAS

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Boothbay Fund Management's ERAS Position: Q1 2026 in Review

Boothbay Fund Management sold out of Erasca (ERAS) in Q1 2026, closing a stake of 188,467 shares — an estimated $701K sold.

Boothbay Fund Management first reported a position in ERAS in Q4 2025 and held it in 1 quarter. The position peaked at $701K in Q4 2025. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

Boothbay Fund Management reported no remaining Erasca position as of Q1 2026 after selling out during the quarter.
Boothbay Fund Management sold 188,467 Erasca shares in Q1 2026, an estimated $701K.
Boothbay Fund Management first reported a position in Erasca in Q4 2025 and held it in 1 quarter.
Boothbay Fund Management's Erasca position peaked at $701K in Q4 2025.
225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.